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Figure S1. Preparation steps for positive imprints (shims) of CA15 microbead layers. The CA15 microbeads 
suspension is spread on a glass block using a spreading tool consisting of rectangular glass frame which is 
filled with the microbeads suspension and dragged along the glass surface. The microbeads multilayer is 
then left to dry in air and then casted with curable PDMS. After curing for 2 days at room temperature, the 
cured PDMS layer (negative imprint) is peeled off and cleaned by washing with water and detergent. The 
PDMS negative imprint is then replicated with a layer of UV curable polyurethane resin on PET foil which 
is cured under UV light (365 nm, 10W) for 10 min to produce a positive CA15 imprint. This mater imprint 





Figure S2 (a) The Roll-to-Roll-UV Nano-Imprinting Lithography (NIL) machine at our collaborator Joanneum 
Research FmbH (Weiz, Austria) printing facility with a speed up to 30 m min-1. (b) Scheme of the R2R-UV-NIL unit. 1  
Photographs showing the production of (c) a roll of negative acrylate-based bioimprint on PET foil fabricated from 
positive PU imprint shims on PET foil produced with a speed of 1 m min-1. Figures S2a and S2b reprinted with 
permission from ref. 1. Copyright 2016 American Chemical Society. 
 
Fabrication protocol for CA15 particle imprints  
The positive shim imprint (Figure S1) was made using an elastic resin formulated with a PU-acrylate oligomer, 
two acrylate diluents, a photo-initiator (3 wt%)  and a polythiol (10 wt%) for suppressing the O2-inhibition 
(from the air/O2 dissolved in PDMS). The UV curable resin for the final R2R negative imprint contains a 
hydrophilic acrylate, a photo-initiator (3 wt%) and a silicone surfactant (1 wt%) for easy demolding. The 
compositions of the resins are proprietary of Joanneum Research FmbH (Weiz, Austria). The imprint base 
was a PET foil sourced from DuPont Melinex ST505 of thickness 125 µm. 
 
Surface modification protocol for CA15 particle imprints 
 The negative CA15 imprint was treated with oxygen-plasma and then coated with branched polyethylene 
imine (bPEI). It is known that bPEI has certain low toxicity when used as gene-transfer vector in solution. 
This has been widely researched and commented on by a number of authors2,3 for multiple cell types exposed 
to a solution of bPEI. The same polymer has been extensively used for coating nanocarriers for delivery of 
chemotherapeutic agents due to its relatively low toxicity.4 However, in the case of our bPEI surface treated 
imprints, there was no free bPEI in the solution as bPEI is bound to the bioimprint. The CA15 imprint surface 
is further treated with the Pluronic surfactant Poloxamer 407 which is routinely used for passivation of surfaces 
in biomedical equipment (catheters, etc.) exposed to biological fluids to minimise non-specific adsorption of 
cells and biopolymers. Hence during the imprint selectivity experiments, the PBMCs do not come in direct 
contact with bPEI which may otherwise potentially impact their viability in solution. In our selectivity 
experiments, however, all cells were fixed for the purposes of preserving their shape and size, hence there is 





Figure S3 (a) Optical microscopy images (A)-(C) and SEM images (D)-(F) of CA15 negative particle imprints at 




Figure S4. Total cell count for the HL60/PBMCs mixture circulating through the imprint chip over 12 cm CA15 imprint 
at a flow rate of 71 mL/h for channel depth of 250 m as a function of time. The CA15 particle imprints were treated 
subsequently with oxygen plasma and two different concentrations of bPEI (1 wt% and 2 wt%) followed by 1 wt% 







Figure S5 (A) Optical microscopy image (bright field) and (B) fluorescence microscopy image of live HL60 
cells (green) stained using carboxyfluorescein-phospholipid conjugate. (C) Optical microscopy image (bright 
field) and (D) fluorescence microscopy image of fixed HL60 cells (red) stained using Lissamine Rhodamine 
sulfonyl B. 
 
The experimental challenge in performing of the cell shape chromatography experiments with live cells is in 
keeping the cell viability constant throughout the experiment for accounting purposes, rather than the 
experiment itself, which is exactly the same for live and fixed cells. The potential differences may arise when 
cells dye and change their shape and size (e.g. deflate) during the experiment. As we cannot control the cell 
viability in flow-through conditions which take a long time and have batch to batch variations, for the sake of 
simplicity we did the experiments with fixed cells (both HL60 and PBMCs). We have demonstrated that there 
is no substantial change of the shape and size of the live HL60 cells before and after fixing (see Figure S5, 
Supporting Information). The preservation of the cells shape and size is all that matters when it comes to their 
interaction with the size-matched particle imprint. More detailed studies with live cell systems will be subject 




Table S1. Calculated channel cross-sectional area A, flow velocity v, resident time tr, the equivalent channel 
diameter DH and the dimensionless Reynolds number Re=DHv/ for the flowrates, channel depths and 
imprint lengths used in our cell recognition experiments. Q=Av; A=dw; tr=L/v;  DH=4A/P with P=2(L+d) 
being the average perimeter of the channel cross-section. Here =1.0510-3 Pa s is the viscosity of the aqueous 
























71 125 4 6.25E-07 3.16E-02 1.27E+00 2.4E-04 7.4 
95 125 4 6.25E-07 4.22E-02 9.47E-01 2.4E-04 9.9 
140 125 4 6.25E-07 6.22E-02 6.43E-01 2.4E-04 14.6 
71 125 8 6.25E-07 3.16E-02 2.54E+00 2.4E-04 7.4 
95 125 8 6.25E-07 4.22E-02 1.89E+00 2.4E-04 9.9 
140 125 8 6.25E-07 6.22E-02 1.29E+00 2.4E-04 14.6 
71 125 12 6.25E-07 3.16E-02 3.80E+00 2.4E-04 7.4 
95 125 12 6.25E-07 4.22E-02 2.84E+00 2.4E-04 9.9 
140 125 12 6.25E-07 6.22E-02 1.93E+00 2.4E-04 14.6 
71 250 4 1.25E-06 1.58E-02 2.54E+00 4.8E-04 7.2 
95 250 4 1.25E-06 2.11E-02 1.89E+00 4.8E-04 9.7 
140 250 4 1.25E-06 3.11E-02 1.29E+00 4.8E-04 14.3 
71 250 8 1.25E-06 1.58E-02 5.07E+00 4.8E-04 7.2 
95 250 8 1.25E-06 2.11E-02 3.79E+00 4.8E-04 9.7 
140 250 8 1.25E-06 3.11E-02 2.57E+00 4.8E-04 14.3 
71 250 12 1.25E-06 1.58E-02 7.61E+00 4.8E-04 7.2 
95 250 12 1.25E-06 2.11E-02 5.68E+00 4.8E-04 9.7 
140 250 12 1.25E-06 3.11E-02 3.86E+00 4.8E-04 14.3 
71 500 4 2.50E-06 7.89E-03 5.07E+00 9.1E-04 6.9 
95 500 4 2.50E-06 1.06E-02 3.79E+00 9.1E-04 9.2 
140 500 4 2.50E-06 1.56E-02 2.57E+00 9.1E-04 13.6 
71 500 8 2.50E-06 7.89E-03 1.01E+01 9.1E-04 6.9 
95 500 8 2.50E-06 1.06E-02 7.58E+00 9.1E-04 9.2 
140 500 8 2.50E-06 1.56E-02 5.14E+00 9.1E-04 13.6 
71 500 12 2.50E-06 7.89E-03 1.52E+01 9.1E-04 6.9 






Table S2. Calculated HL60 and PBMC sedimentation velocities, 2( ) /(18 )s c m cu gD=  −   and sedimentation 
pathway lengths s r sl t u=  over the residence time for different combinations of flowrates, channel depths and 
imprint lengths used in our cell recognition experiments. Here 31125c kg m
− = is the average cell mass density, 
31010m kg m
− = is the aqueous media mass density, =1.0510-3 Pa s is the viscosity of the aqueous media 
(PBS at 25 C), 29.81g ms−= is the gravity acceleration and 14.5cD m=   is the average cell diameter for HL60 



























71 125 4 4.0E-04 1.5E-04 1.3E-01 4.9E-02 
95 125 4 3.0E-04 1.1E-04 9.5E-02 3.7E-02 
140 125 4 2.0E-04 7.8E-05 6.5E-02 2.5E-02 
71 125 8 4.0E-04 1.5E-04 2.5E-01 9.8E-02 
95 125 8 3.0E-04 1.1E-04 1.9E-01 7.3E-02 
140 125 8 2.0E-04 7.8E-05 1.3E-01 5.0E-02 
71 125 12 4.0E-04 1.5E-04 3.8E-01 1.5E-01 
95 125 12 3.0E-04 1.1E-04 2.9E-01 1.1E-01 
140 125 12 2.0E-04 7.8E-05 1.9E-01 7.5E-02 
71 250 4 8.0E-04 3.1E-04 1.3E-01 4.9E-02 
95 250 4 5.9E-04 2.3E-04 9.5E-02 3.7E-02 
140 250 4 4.0E-04 1.6E-04 6.5E-02 2.5E-02 
71 250 8 8.0E-04 3.1E-04 2.5E-01 9.8E-02 
95 250 8 5.9E-04 2.3E-04 1.9E-01 7.3E-02 
140 250 8 4.0E-04 1.6E-04 1.3E-01 5.0E-02 
71 250 12 8.0E-04 3.1E-04 3.8E-01 1.5E-01 
95 250 12 5.9E-04 2.3E-04 2.9E-01 1.1E-01 
140 250 12 4.0E-04 1.6E-04 1.9E-01 7.5E-02 
71 500 4 1.6E-03 6.1E-04 1.3E-01 4.9E-02 
95 500 4 1.2E-03 4.6E-04 9.5E-02 3.7E-02 
140 500 4 8.1E-04 3.1E-04 6.5E-02 2.5E-02 
71 500 8 1.6E-03 6.1E-04 2.5E-01 9.8E-02 
95 500 8 1.2E-03 4.6E-04 1.9E-01 7.3E-02 
140 500 8 8.1E-04 3.1E-04 1.3E-01 5.0E-02 
71 500 12 1.6E-03 6.1E-04 3.8E-01 1.5E-01 
95 500 12 1.2E-03 4.6E-04 2.9E-01 1.1E-01 
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